This strategic alliance will give a unique advantage to pharmaceutical & bio-tech customers –
accelerating the go-to-market of their drug-device combination products by offering
analytical chemistry, drug compatibility lab testing and expert advice.
LEUVEN Belgium, March 14, 2023
Nemera, a leading partner for drug delivery device solutions and combination product services and
Nelson Labs Europe, a global leader in microbiological and analytical chemistry testing and expert
advisory services for the medical device and pharmaceutical industries announced that they are
strengthening their already existing partnership for the benefit of their customers and patients.
This non-exclusive partnership provides Nemera extractables & leachables, biocompatibility,
microbiology, and chemical testing; providing an integrated services offering to customers for their
drug/device combination products and helping to accelerate their time to market.
“We’re very happy that we can offer our lab testing services and associated scientific knowledge to a
company like Nemera where we share the same premise of improving the lives of patients worldwide.
We are convinced that by combining our forces we will bring many benefits to both the end customer
and ultimately the patient” says Eric Meyers, Senior Vice President EMEAA, Nelson Labs.
Marc Hämel, CEO of Nemera said, “We’ve been relying on Nelson Labs’ expertise for several years
now. This announcement comes at the perfect time for Nemera as we passionately grow our business
as an integrated services partner. Our goal is to bring the most benefits possible when it comes to
front-end innovation & device development, clinical & commercial device manufacturing, and
combination product services to customers and ultimately patients.”
At Nemera and Nelson Labs, we collectively believe building positive relationships in business is one
of the most important foundations for success and we look forward to a solid collaboration.
About Nelson Labs
Nelson Labs is a global leader in microbiological and analytical chemistry testing and advisory services
for the medical device and pharmaceutical industries. Nelson Labs serves over 3,000 customers
across 15 facilities in the United States, Mexico, Asia, and Europe. We have a comprehensive array of
over 900 laboratory tests supporting our customers from initial product development and
sterilization validation, through regulatory approval and ongoing product testing for sterility, safety,
and quality assurance. We are regarded as a best-in-class partner with a strong track record of
collaborating with customers to solve complex issues.
Based in Leuven, Belgium, Nelson Labs Europe specializes in providing premium extractables &
leachables testing services to the pharmaceutical and medical device industries. We also support
pharmaceutical companies across the globe in developing worldwide compliance testing strategies to
qualify container/closure applications and pharmaceutical production equipment from an
extractables & leachables perspective.
With decades of expertise, we stand behind the quality of our results and the strength or our
customer partnerships. Along with our sister companies Sterigenics and Nordion, we are part of
Sotera Health, the leading protector of global health.
Safeguarding Global Health® – with every test we complete.
As a world-leading drug delivery device solutions provider, our purpose of putting patients first
enables us to design and manufacture devices that maximize treatment efficacy.
We are a holistic partner and help our customers succeed in the sprint to market of their
combination products. From early device strategy to state-of-the-art manufacturing, we’re
committed to the highest quality standards.
Agile and open-minded, we work with our customers as colleagues. Together, we go the extra mile to
fulfil our mission. To know more, visit: https://www.nemera.net/
Media Contactperson at Nelson Labs
Sr. Director of Global Marketing
Media Contactperson at Nemera
Global Communications Manager
Click here to download the PDF.